参考文献/References:
[1] NG E W M,SHIMA D T,CALIAS P,et al.Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease[J].Nature Reviews Drug Discovery,2006,5(2):123-132.DOI:10.1038/nrd1955.
[2] BING Tao,SHANGGUAN Dihua,WANG Yinsheng.Facile discovery of cell-surface protein targets of cancer cell aptamers[J].Molecular and Cellular Proteomics,2015,14(10):2692-2700.DOI:10.1074/mcp.m115.051243.
[3] ZHOU Wei,ZHAO Libo,YUAN Hongyu,et al.A new small cell lung cancer biomarker identified by Cell-SELEX generated aptamers[J].Experimental Cell Research,2019,382(2/3):111478.DOI:10.1016/j.yexcr.2019.06.023.
[4] LYU Jing,ZHEN Xiaoxiao,LI Dandan,et al.Generation of an aptamer targeting receptor-type tyrosine protein phosphatase F[J].Analytical Chemistry,2023,95(2):1228-1233.DOI:10.1021/acs.analchem.2c03988.
[5] ZAMAY G S,KOLOVSKAYA O S,ZAMAY T N,et al.Aptamers selected to postoperative lung adenocarcinoma detect circulating tumor cells in human blood[J].Molecular Therapy,2015,23(9):1486-1496.DOI:10.1038/mt.2015.108.
[6] WU Xiaoqiu,LIU Honglin,HAN Dongmei,et al.Elucidation and structural modeling of CD71 as a molecular target for cell-specific aptamer binding[J].Journal of the American Chemical Society,2019,141(27):10760-10769.DOI:10.1021/jacs.9b03720.
[7] JIA Wenting,REN Caiping,WAN Lei,et al.CD109 is identified as a potential nasopharyngeal carcinoma biomarker using aptamer selected by cell-SELEX[J].Oncotarget,2016,7(34):55328-55342.DOI:10.18632/oncotarget.10530.
[8] WANG Guodong,LIU Jun,CHEN Ke,et al.Selection and characterization of DNA aptamer against glucagon receptor by cell-SELEX[J].Scientific Reports,2017,7(1):7179.DOI:10.1038/s41598-017-05840-w.
[9] CALZADA V,MORENO M,NEWTON J,et al.Development of new PTK7-targeting aptamer-fluorescent and radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept[J].Bioorganic and Medicinal Chemistry,2017,25(3):1163-1171.DOI:10.1016/j.bmc.2016.12.026.
[10] DHARMASIRI U,BALAMURUGAN S,ADAMS A A,et al.Highly efficient capture and enumeration of low abundance prostate cancer cells using prostate-specific membrane antigen aptamers immobilized to a polymeric microfluidic device[J].Electrophoresis,2009,30(18):3289-3300.DOI:10.1002/elps.200900141.
[11] XU Ye,PHILLIPS J A,YAN Jilin,et al.Aptamer-based microfluidic device for enrichment, sorting, and detection of multiple cancer cells[J].Analytical Chemisitry,2009,81(17):7436-7442.DOI:10.1021/ac9012072.
[12] 刁勇,王立强,邱飞.抗肿瘤适体药物的研究进展[J].中国生化药物杂志,2009,30(6):415-418.
[13] RONG Yuan,CHEN Hao,ZHOU Xuefeng,et al.Identification of an aptamer through whole cell-SELEX for targeting high metastatic liver cancers[J].Oncotarget,2016,7(7):8282-8294.DOI:10.18632/oncotarget.6988.
[14] CERCHIA L,DUCONGé F,PESTOURIE C,et al.Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase[J].Plos Biology,2005,3(4):697-704.DOI:10.1371/journal.pbio.0030123.
[15] ZUEVA E,RUBIO L I,DUCONGé F,et al.Metastasis-focused cell-based SELEX generates aptamers inhibiting cell migration and invasion[J].International Jouranl of Cancer,2011,128(4):797-804.DOI:10.1002/ijc.25401.
[16] ESPOSITO C L,PASSARO D,LONGOBARDO I,et al.A neutralizing RNA aptamer against EGFR causes selective apoptotic cell death[J].Plos One,2011,6(9):e24071.DOI:10.1371/journal.pone.0024071.
[17] MAHLKNECHT G,MARON R,MANCINI M,et al.Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth[J].Proceedings of the National Acadmey of Sciences of the United States of Americal,2013,110(20):8170-8175.DOI:10.1073/pnas.1302594110.
[18] KOLOVSKAYA O S,ZAMAY T N,ZAMAY A S,et al.DNA-aptamer/protein interaction as a cause of apoptosis and arrest of proliferation in ehrlich ascites adenocarcioma cells[J].Biologicheskie Membrany,2013,30(5/6):398-411.DOI:10.7868/S023347551305006X.
[19] CAMORANI S,ESPOSITO C L,RIENZO A,et al.Inhibition of receptor signaling and of glioblastoma-derived tumor growth by a novel PDGFRβ aptamer[J].Molecular Therapy,2014,22(4):828-841.DOI:10.1038/mt.2013.300.
[20] ESPOSITO C L,VAN ROOSBROECK K,SANTAMARIA G,et al.Selection of a nuclease-resistant RNA aptamer targeting CD19[J].Cancers,2021,13(20):5220.DOI:10.3390/cancers13205220.
[21] MERAVIGLIA-CRIVELLI D,VILLANUEVA H,MENON A P,et al.A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression[J].Molecular Therapy-Nucleic Acids,2022,29:413-425.DOI:10.1016/j.omtn.2022.07.017.
[22] KELLY L,KRATSCHMER C,MAIER K E,et al.Improved synthesis and in vitro evaluation of an aptamer ribosomal toxin conjugate[J].Nucleic Acid Therapeutics,2016,26(3):156-165.DOI:10.1089/nat.2015.0599.
[23] QIAO Yan,SHI Yanli,JI Mengmeng,et al.Selection and identification of a prohibitin 2-binding DNA aptamer for tumor tissue imaging and targeted chemotherapy[J].International Journal of Biological Macromolecules,2024,259:129002.DOI:10.1016/j.ijbiomac.2023.129002.
[24] GAO Fei,YIN Jianhui,CHEN Yan,et al.Recent advances in aptamer-based targeted drug delivery systems for cancer therapy[J].Frontiers in Bioengineering and Biotechnology,2022,10:972933.DOI:10.3389/fbioe.2022.972933
[25] DUAN Tao,XU Zhuobin,SUN Fumo,et al.HPA aptamer functionalized paclitaxel-loaded PLGA nanoparticles for enhanced anticancer therapy through targeted effects and microenvironment modulation[J].Biomedicine and Pharmacothrapy,2019,117:109121.DOI:10.1016/j.biopha.2019.109121.
[26] MANOOCHEHRI H,JALALI A,TANZADEHPANAH H,et al.Aptamer-conjugated nanoliposomes containing COL1A1 siRNA sensitize CRC cells to conventional chemotherapeutic drugs[J].Colloids and Surfaces B: Biointerfaces,2022,218:112714.DOI:10.1016/j.colsurfb.2022.112714.
[27] MEHRNIA S S,HASHEMI B,MOWLA S J,et al.Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles[J].Radiation Oncology,2021,16(1):33.DOI:10.1186/s13014-021-01751-3.
[28] WANG Tengfei,LUO Yu,LYU Haiyin,et al.Aptamer-based erythrocyte-derived mimic vesicles loaded with siRNA and DOX for the targeted treatment of multidrug resistance tumors[J].ACS Applied Materials and Interface,2019,11(49):45455-45466.DOI:10.1021/acsami.9b16637.
[29] BOLTZ A,PIATER B,TOLEIKIS L,et al.Bi-specific aptamers mediating tumor cell lysis[J].Journal of Biological Chemisty,2011,286(24):21896-21905.DOI:10.1074/jbc.M111.238261.
[30] ZHU Huijie,LI Jin,ZHANG Xiaobin,et al.Nucleic acid aptamer-mediated drug delivery for targeted cancer therapy[J].Chemmedchem,2014,10(1):39-45.DOI:10.1002/cmdc.201402312.
[31] ZHONG Yi, ZHAO Jiayao,LI Jiazhao,et al.Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics[J].Analytical Biochemistry,2020,598:113620.DOI:10.1016/j.ab.2020.113620.